chr19-50402116-C-G
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The ENST00000440232.7(POLD1):āc.581C>Gā(p.Ser194Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000455 in 1,611,626 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S194F) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000440232.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLD1 | NM_002691.4 | c.581C>G | p.Ser194Cys | missense_variant | 5/27 | ENST00000440232.7 | NP_002682.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POLD1 | ENST00000440232.7 | c.581C>G | p.Ser194Cys | missense_variant | 5/27 | 1 | NM_002691.4 | ENSP00000406046 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000578 AC: 88AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000581 AC: 144AN: 247890Hom.: 0 AF XY: 0.000619 AC XY: 83AN XY: 133980
GnomAD4 exome AF: 0.000442 AC: 645AN: 1459304Hom.: 0 Cov.: 34 AF XY: 0.000452 AC XY: 328AN XY: 725802
GnomAD4 genome AF: 0.000578 AC: 88AN: 152322Hom.: 0 Cov.: 32 AF XY: 0.000658 AC XY: 49AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Jul 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Apr 28, 2017 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 30, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 21, 2020 | - - |
Hereditary cancer-predisposing syndrome Benign:2
Benign, criteria provided, single submitter | curation | Sema4, Sema4 | Apr 23, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2024 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
See cases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University Hospital Muenster | Dec 21, 2022 | ACMG categories: BS2,BP4 - |
Colorectal cancer, susceptibility to, 10 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Malignant tumor of breast Benign:1
Likely benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The POLD1 p.Ser194Cys variant was not identified in the literature. The variant was identified in dbSNP (ID: rs144656348) as "With Uncertain significance allele", ClinVar (classified as likely benign by Invitae, GeneDx and two other submitters; as uncertain significance by Ambry Genetics), and in LOVD 3.0 (1x) .The variant was identified in control databases in 178 of 273686 chromosomes (1 homozygous) at a frequency of 0.0007 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Other in 8 of 6358 chromosomes (freq: 0.001), Latino in 1 of 34170 chromosomes (freq: 0.00003), European in 68 of 124668 chromosomes (freq: 0.0006), European Finnish in 84 of 25520 chromosomes (freq: 0.003), and South Asian in 17 of 30346 chromosomes (freq: 0.0006), while the variant was not observed in the African, Ashkenazi Jewish, and East Asian, populations. The p.Ser194 residue is conserved in mammals but not in more distantly related organisms however computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at